Edition:
India

Profile: Wockhardt Ltd (WCKH.BO)

WCKH.BO on Bombay Stock Exchange

1,008.55INR
29 Jul 2016
Change (% chg)

Rs16.45 (+1.66%)
Prev Close
Rs992.10
Open
Rs995.00
Day's High
Rs1,033.50
Day's Low
Rs990.00
Volume
307,235
Avg. Vol
175,802
52-wk High
Rs1,748.20
52-wk Low
Rs706.35

Wockhardt Limited (Wockhardt) is an India-based pharmaceutical and biotechnology company. The Company is focused in biotech research program for the development of diabetes related treatment. It has approximately three research centers and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. Its products include Ace Proxyvon, Bio-Corneum, Clopione, Decdan, Gleedox, H.B Rich, Immumod, Kelo-Cote, Lanagesic, Manix Herbal, Nadimix, Obax, Platin, Rozuone, Sammy, TeMax, Vitix, Wepox and Zedex, among others. It markets insulin and glargine, under the brands Wosulin and Glaritus respectively. It offers Wosulin in the form of a disposable pen, a Wockhardt device. It offers glargine for diabetologists and diabetic patients. Its drug candidates WCK 771, WCK 2349 and WCK 4873 received qualified infectious disease product (QIDP) status in the United States.

Company Address

Wockhardt Ltd

Wockhardt Towers
Bandra Kurla Complex, Bandra (Ea
Bandra (East)
MUMBAI     400051
P: +9122.26534444
F: +9122.26534242

Company Web Links